Combining proteasome inhibitors with autophagy inhibitors disrupts acute myeloid leukemia (AML) cells' proteostasis, enhancing treatment efficacy and inducing programmed cell death. A novel ...

The Cyprus Securities and Exchange Commission (CySEC) has reached a €150,000 settlement with investment firm Aquilla Nummus ...

Acute myeloid leukemia (AML) is a type of blood and bone marrow cancer. AML can affect people of any age, but it is most common in adults. AML occurs when bone marrow produces abnormal blood cells, ...

Nearly a third of law firms checked by the SRA for their approach to anti-money laundering in the past year were ...

The FDA has approved revumenib (Revuforj; Syndax Pharmaceuticals) for patients 1 year and older with relapsed or refractory acute myeloid leukemia with a susceptible nucleophosmin 1 ( NPM1) mutation ...

Coinbase has been fined €21.5 million by the Central Bank of Ireland after failing to monitor suspicious crypto transactions.

Q3 2025 Management View James Dentzer, President and CEO, emphasized continued progress in the TakeAim Lymphoma study evaluating emavusertib in combination with ibrutinib in primary CNS lymphoma ...

Ireland has issued its first crypto enforcement action as Coinbase Europe admits flaws in monitoring 30 million transactions.

The U.S. Food and Drug Administration (FDA) has approved Revuforj (revumenib), which is a menin inhibitor, for the treatment of relapsed or refractory acute myeloid leukemia (AML) with a susceptible ...

The US FDA has approved the supplemental new drug application (sNDA) for revumenib (Revuforj) in the treatment of relapsed or refractory (R/R) mutant nucleophosmin 1 (m NPM1) acute myeloid leukemia ...

The therapeutic arsenal for the management of AML has expanded significantly in recent years. Before 2017, newly diagnosed AML was treated with either standard cytarabine- and anthracycline-based ...